These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3719876)

  • 1. Studies on chemical carcinogens and mutagens. XXXVII. A simple method to predict ultimate structures of chemical mutagens, and probably carcinogens.
    Kawazoe Y; Fujiura T; Kohda K
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1755-63. PubMed ID: 3719876
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism, mutagenicity, and DNA binding of biphenyl-based azodyes.
    Martin CN; Kennelly JC
    Drug Metab Rev; 1985; 16(1-2):89-117. PubMed ID: 3905319
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term assays to predict carcinogenicity. Metabolic activation.
    Venitt S; Bartsch H; Becking G; Fuchs RP; Hofnung M; Malaveille C; Matsushima T; Mendelsohn ML; Pegg AE; Roberfroid M
    IARC Sci Publ; 1986; (83):439-55. PubMed ID: 3305349
    [No Abstract]   [Full Text] [Related]  

  • 4. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 5. Methods for analysis of the mutagenicity of indirect mutagens/carcinogens in eukaryotic cells.
    Madle S; Obe G
    Hum Genet; 1980; 56(1):7-20. PubMed ID: 7009387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagens and carcinogens in foods.
    Furihata C; Matsushima T
    Annu Rev Nutr; 1986; 6():67-94. PubMed ID: 3524625
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 8. The L5178Y/TK gene mutation assay for the detection of chemical mutagens.
    Amacher DE; Turner GN
    Ann N Y Acad Sci; 1983; 407():239-52. PubMed ID: 6410961
    [No Abstract]   [Full Text] [Related]  

  • 9. The chemical activation of non-mutagenic nitrated polycyclic aromatic hydrocarbons to mutagens.
    Karpinsky GE; McCoy EC; Rosenkranz HS; Mermelstein R
    Mutat Res; 1982 Feb; 92(1-2):29-37. PubMed ID: 7045649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the genotoxic activity of some mycotoxins using Escherichia coli in the SOS spot test.
    Auffray Y; Boutibonnes P
    Mutat Res; 1986; 171(2-3):79-82. PubMed ID: 3092039
    [No Abstract]   [Full Text] [Related]  

  • 11. International Commission for Protection Against Environmental Mutagens and Carcinogens. Approaches to SAR in carcinogenesis and mutagenesis. Prediction of carcinogenicity/mutagenicity using MULTI-CASE.
    Klopman G; Rosenkranz HS
    Mutat Res; 1994 Feb; 305(1):33-46. PubMed ID: 7508546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of biphenyl ethers on the hepatic mixed--function oxidase (MFO) systems and on the conversion of procarcinogens to mutagens.
    Miyauchi M; Uematsu T
    Bull Environ Contam Toxicol; 1990 Sep; 45(3):422-9. PubMed ID: 2257338
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenicity and structure-mutagenicity relationships of furoquinolines, naturally occurring alkaloids of the Rutaceae.
    Paulini H; Waibel R; Schimmer O
    Mutat Res; 1989 Nov; 227(3):179-86. PubMed ID: 2682236
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural alerts to genotoxicity: the interaction of human and artificial intelligence.
    Rosenkranz HS; Klopman G
    Mutagenesis; 1990 Jul; 5(4):333-61. PubMed ID: 2398817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo[c]phenanthrene.
    Jerina DM; Sayer JM; Yagi H; Croisy-Delcey M; Ittah Y; Thakker DR; Wood AW; Chang RL; Levin W; Conney AH
    Adv Exp Med Biol; 1981; 136 Pt A():501-23. PubMed ID: 7046379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 18. International Commission for Protection Against Environmental Mutagens and Carcinogens. The importance of the hydrophobic interaction in the mutagenicity of organic compounds.
    Debnath AK; Shusterman AJ; Lopez de Compadre RL; Hansch C
    Mutat Res; 1994 Feb; 305(1):63-72. PubMed ID: 7508548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Commission for Protection Against Environmental Mutagens and Carcinogens. Two million rodent carcinogens? The role of SAR and QSAR in their detection.
    Ashby J
    Mutat Res; 1994 Feb; 305(1):3-12. PubMed ID: 7508545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.